Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale

The Relationship Between Evaluation Methods for Chemotherapy-Induced Peripheral Neuropathy

(2019) Yoichiro Yoshida et al.   Scientific Reports

Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Ca

(2018) Hui Lin Cheng et al.   Asia-Pacific Journal of Clinical Oncology

Development and Validation of 11 Symptom Indexes to Evaluate Response to Chemotherapy for Advanced Cancer

(2017) David Cella et al.   Journal of the National Comprehensive Cancer Network

Oxaliplatin-Induced Neuropathy in Colorectal Cancer: Many Questions With Few Answers

(2013) Ahmed Hussein Zedan et al.   Clinical Colorectal Cancer

Importance and Relevance of Pulmonary Symptoms Among Patients Receiving Second- and Third-Line Treatment for Advanced Non–Small-Cell Lung Cancer: Support for the Content Validity of the 4-Item Pulmonary Symptom Index

(2012) Susan Magasi et al.   Clinical Lung Cancer

Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology

(2012) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Longitudinal assessment of oxaliplatin-induced neuropathy

(2012) S. B. Park et al.   NEUROLOGY

Impact of oxaliplatin-induced neuropathy: a patient perspective

(2012) Barbara K. Bennett et al.   SUPPORTIVE CARE IN CANCER

Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity

(2011) Paulo M. Hoff et al.   Clinical Colorectal Cancer

Oxaliplatin-Induced Neuropathy in Colorectal Cancer

(2011) Andrew Weickhardt et al.   Journal of Oncology

Constructing a Conceptual Framework of Patient-Reported Outcomes for Metastatic Hormone-Refractory Prostate Cancer

(2010) David T. Eton et al.   VALUE IN HEALTH

Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report

(2009) Margaret Rothman et al.   VALUE IN HEALTH

A Conceptual Model of the Experience of Dyspnea and Functional Limitations in Chronic Obstructive Pulmonary Disease

(2009) David E. Victorson et al.   VALUE IN HEALTH